Your session is about to expire
← Back to Search
18F-DOPA PET/CT Imaging Optimization
Study Summary
This trial is looking at using 18F-DOPA PET/CT imaging in specific patient populations to see if it can help optimize images and identify gallbladder activity patterns.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I cannot lie flat for 20-30 minutes.You do not have a way for the study drug to be given through a vein.I am under or over 18 and may have a neuroendocrine tumor.I am an adult suspected to have Parkinson's disease or Lewy body dementia.I am under 18 and have been diagnosed with congenital hyperinsulinism.My weight is under 225 kg.I am under or over 18 with a brain tumor.My child cannot lie flat for 20-30 minutes and cannot be sedated safely.I am under 18 and have been diagnosed with neuroblastoma.I have had my gallbladder removed.
- Group 1: 18F-DOPA injection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does 18F-DOPA carry any considerable risks for those who take it?
"There is both efficacy and safety data available for 18F-DOPA, as it has progressed to Phase 3 trials. Our team rates the safety of this medication as a 3."
Are patients still being accepted for this treatment program?
"That is correct, the clinical trial mentioned is still recruiting patients. The listing on clinicaltrials.gov shows that it was posted on 1/20/2021 and last edited on 4/11/2022. They are enrolling 800 people from 1 site."
Do we have a solid understanding of how 18F-DOPA works?
"There are a total of 16 ongoing clinical trials for 18F-DOPA. Of these, 6 have progressed to Phase 3 testing. The majority of these trials are based in Dayton, Ohio; however, there are 44 research sites across the United States."
What does 18F-DOPA help alleviate symptoms for?
"18F-DOPA can be used to combat heart failure, edema, and acute pulmonary edema."
Share this study with friends
Copy Link
Messenger